Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Study Suggests Legalizing Marijuana Lowers Suicide Rates Among Seniors

States that allowed recreational marijuana stores to open experienced a drop in suicide rates among older residents, according to a recent analysis that reviewed more than twenty years of data from across the U.S. The findings suggest a clear association between the start of legal cannabis sales and a measurable decline in suicides among adults later in life.

The study analyzed monthly suicide figures from all 50 states. The goal was to examine whether expanded access to cannabis, specifically through regulated retail outlets, had any observable connection to mental health.

The researchers found that suicide rates fell among people aged 45 and over in states with recreational marijuana stores. The decline was most noticeable among men, a group that has long had higher rates of suicide than women. Men in this age range are also likely to report using cannabis to cope with chronic pain, which is a known contributor to depression and suicide risk.

The analysis did not show similar changes among younger people. It also found no reduction in suicide rates in states that legalized adult-use marijuana but had yet to open retail locations. According to the authors, this distinction points to access rather than cannabis legalization on paper as the key factor.

The study found no evidence that expanded marijuana availability led to an increase in suicides. This runs counter to concerns raised by critics of legalization, who have warned that broader cannabis use could worsen mental health, particularly among younger adults.

The paper also addressed the broader factors that contribute to suicide risk, pointing to pain management as an area that has received limited attention in previous research. They argue that understanding how cannabis may alleviate underlying physical discomfort adds a new dimension to debates over marijuana policy.

To rule out other explanations, the researchers accounted for a range of additional policies and economic factors. Their analysis included alcohol and tobacco taxes, as well as several opioid-related measures such as prescription limits, pill mill regulations, and drug monitoring programs. None of these factors explained the decline they observed.

The findings come amid ongoing concern over the rate of suicide in the United States, which remains close to record levels, particularly among senior and middle-aged adults. While the reduction associated with cannabis dispensaries was relatively small, the researchers emphasize that even incremental improvements can translate into lives saved when applied across large populations.

The authors cautioned that more research is needed to understand why the association exists and how cannabis use may influence mental health in different groups. Entities like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) operating licensed marijuana outlets will be glad that their products could be having such unintended positive effects on their users and potentially saving lives.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Derivatives Show Promise in Treating Ovarian Cancer

Researchers searching for better ways to treat ovarian cancer have reported encouraging results from laboratory tests involving two marijuana compounds. According to a new study, both THC and CBD were able to slow the growth of ovarian cancer cells, and when used together, they were particularly effective at killing existing malignant cells.

The findings, published in the journal Frontiers in Pharmacology, are still at an early stage and are limited to cell-based studies. However, scientists say the results point to a possible new direction for therapies targeting a disease that is often detected late and remains difficult to manage with current drugs.

CBD, which does not produce a psychoactive effect, and THC, which does, have previously shown anti-cancer activity in studies involving other tumor types. Based on that evidence, the research team examined how both substances affected ovarian cancer cells grown in the laboratory.

The scientists worked with two types of ovarian cancer cells. One was responsive to platinum-based chemotherapy, while the other was resistant to it. Each cell line was exposed separately to CBD, THC, and a combination of the two. Healthy cells were also included to assess potential toxicity.

Results showed that cancer cells treated with either compound produced fewer colonies and displayed reduced growth. The strongest effects were observed when CBD and THC were applied together. While each substance alone had a limited ability to kill cancer cells outright, their combined use led to a significant increase in cancer cell death. Researchers believe the compounds may act through different biological processes that reinforce each other when paired.

Further tests revealed that treated cancer cells were less able to move, an important finding since the spread of cancer to other organs is a leading cause of death in ovarian cancer patients. If confirmed in further studies, this could mean the compounds help limit metastasis.

Notably, both chemotherapy-sensitive and resistant cancer cells reacted in similar ways. Healthy cells showed little change, raising the possibility that treatments based on these compounds might be easier to tolerate than current options.

To understand how the effects occur, the researchers examined a key cellular signaling system known as the PI3K/AKT/mTOR pathway, which is often overactive in ovarian tumors. THC and CBD appeared to bring this pathway back under control, reducing cancer cell growth and survival.

Despite the promising data, researchers caution that extensive additional studies are required. Animal testing and clinical trials will be necessary to determine safety, dosage, and real-world effectiveness. For now, the findings offer a potential foundation for future therapies aimed at improving outcomes for patients with ovarian cancer.

These findings come at a time when reports show President Trump is considering using an executive order to shift marijuana from Schedule I to III of the CSA. The wider marijuana industry, including enterprises like SNDL Inc. (NASDAQ: SNDL), welcomes these positive developments that could help to support efforts to reform drug policies around the world.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Trump to Sign Executive Order Rescheduling Marijuana

President Donald Trump is expected to announce a plan that could shift cannabis from Schedule I to Schedule III under federal drug law, a change that would, for the first time, formally acknowledge cannabis as having accepted medical use in the U.S.

If finalized, the move would represent one of the most consequential adjustments to federal marijuana policy in years. It could reshape how cannabis businesses are taxed, how medical marijuana is viewed within healthcare, and how federal agencies interact with a market that has long existed in legal gray areas. Still, the proposal stops well short of nationwide legalization and has sparked mixed reactions across the industry.

Under federal law, Schedule III drugs are considered to have accepted medical use and a lower likelihood of abuse than substances listed in Schedules I or II. This category includes drugs such as anabolic steroids, ketamine, and certain codeine-based pain medications.

The most immediate practical impact could come through the tax code. Businesses that deal in Schedule I or II substances are barred from deducting ordinary operating expenses under Internal Revenue Service rule 280E.

Industry executives say relief from this provision could significantly improve cash flow for licensed operators and make long-term investment more realistic. However, they caution that other obstacles, including limited access to banking services, would remain.

Supporters argue that Schedule III status would further legitimize medical marijuana and help integrate it into conventional healthcare systems. They say federal recognition could encourage research, standardization, and broader acceptance among doctors and patients.

Some industry leaders, however, are wary of unintended consequences. Some warn that shifting marijuana into a medical category could expose existing operators to new forms of federal liability. They caution that treating THC as a prescription substance could allow pharmaceutical companies to dominate the market with synthetic alternatives, while dispensaries and growers could face scrutiny under federal drug and consumer protection laws.

Advocates are divided on how the shift might affect social equity. Some believe formal recognition of medical use could draw more people into the legal market, including those from communities disproportionately harmed by past enforcement. Others worry it could widen the gap between well-funded companies and small, independent businesses.

Questions also remain about how rescheduling would align with ongoing debates over hemp-derived THC products. Joe Gerrity, chief executive of Crescent Canna, pointed to what he called a contradiction between easing marijuana rules while moving to restrict or eliminate hemp-based alternatives through future legislation. He said the change could either push lawmakers toward a clearer national policy or deepen existing confusion.

For many in the cannabis space, rescheduling would mark long-overdue acknowledgment after years of stigma. Still, there is broad agreement that the change, while historic, would not amount to full legalization. Without further action on insurance, banking, federal enforcement, and clear FDA pathways, both patients and businesses would continue to navigate a complex and uncertain system.

It remains to be seen how entities like Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) will adjust their long-term strategies and operations in light of this expected executive order rescheduling marijuana federally.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Ohio Governor Signals He Will Sign Bill Banning Hemp Intoxicants

Ohio Governor Mike DeWine stated that he plans to sign legislation that would prohibit the sale of intoxicating hemp products and revise parts of the state’s recreational cannabis law that voters approved in 2023. The measure also introduces new criminal provisions related to cannabis possession and sales.

Speaking with reporters during a morning appearance, DeWine said the bill would bring much-needed oversight to a market he believes has operated with little control.

The bill, Senate Bill 56, passed the state Senate earlier last week and now awaits the governor’s signature. If signed before the end of the year, the law could begin taking effect as early as March.

DeWine has been pressing lawmakers to address the issue since early 2024, repeatedly calling attention to delta-8 THC products. The products, often sold outside licensed cannabis dispensaries, are commonly found at CBD stores, smoke shops, and gas stations. While derived from hemp, many of the products contain psychoactive levels of THC.

The governor has repeatedly pointed to concerns about children accessing the products. He said the bill would prevent minors from purchasing potent hemp edibles and other THC-infused products at convenience stores. In his view, protecting young people is the most critical outcome of the legislation.

Data from the Ohio Poison Control Center has added urgency to the debate. In January 2024, the agency reported at least 257 cases of delta-8 exposure in recent years. More than 100 incidents occurred in 2023 alone, and 40 involved children younger than six.

Earlier this fall, DeWine attempted to curb sales by issuing a 90-day executive order halting the sale of intoxicating hemp products. The order took effect in mid-October but was quickly challenged in court. A Franklin County judge issued a temporary restraining order that paused enforcement until January. A hearing on the matter is scheduled for January 29.

SB 56 aligns Ohio law with recent federal action that restricts hemp products containing more than 0.4 mg of total THC per package from being sold outside licensed dispensaries. This represents a shift from the Farm Bill 2018, which allowed hemp cultivation if THC levels stayed below 0.3% by weight. Although the federal rule includes a one-year delay, states are permitted to act sooner.

SB 56 also permits beverages containing up to 5mg of THC to remain on the market through the end of 2026.

Beyond hemp regulation, the bill revises the state’s recreational cannabis framework. It lowers allowable THC concentrations in extracts and flower, limits smoking in public areas, and adds restrictions on packaging and transport. Bringing legally purchased cannabis from another state into Ohio would become a criminal offense.

The legislation also reallocates tax revenue, directing 36% of the revenue from recreational cannabis sales to local governments that host dispensaries.

These developments in Ohio are likely to be watched by multistate operators like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), especially regarding the way hemp intoxicants are being outlawed since these actions could offer a model that other states replicate by restricting THC products to licensed marijuana outlets.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Signs LOI to Lease Canning and Manufacturing Facility

Golden Triangle Ventures (OTC: GTVH) (“GTV”) has signed a letter of intent to lease a canning and manufacturing facility intended to serve as a central hub for beverage production, brand development and private-label services. The planned facility is designed to consolidate canning, formulation, white-label production and marketing support under a single operation, supporting the Company’s strategy to build a scalable platform that accelerates product development, improves manufacturing control and creates additional revenue opportunities through partnerships and joint ventures.

To view the full press release, visit https://cnw.fm/kVVVA

About Golden Triangle Ventures, Inc.

Golden Triangle Ventures (OTC: GTVH) is a diversified company developing a portfolio of high-growth businesses across construction, energy, and consumer goods. Through subsidiaries such as GoldenEra Development, GoFast Sports, Deep South Electrical Contractors, and its future Manufacturing & Logistics Division, the company operates a vertically integrated model focused on profitability, innovation, and long-term shareholder value.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Austin, Texas
www.CannabisNewsWire.com
512.354.7000 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Ohio Senate Passes Bill Rolling Back Voter-Passed Marijuana Law

The Ohio Senate has passed a House-revised measure that would scale back parts of the state’s voter-approved cannabis statute and limit where most hemp products can be sold. Senators approved the revised bill on a 22–7 vote, agreeing to the House changes and forwarding the measure to Governor Mike DeWine.

The legislation, introduced by Senator Stephen Huffman, underwent significant revisions over the past several weeks after the two chambers clashed over its scope.

If signed, the bill would roll back parts of the 2023 adult-use cannabis law approved by voters and revive penalties for certain activities that had been permitted. It would also delete protections that prevented discrimination against people who legally use cannabis, including safeguards tied to child custody decisions, access to organ transplants, and some professional licenses.

Advocates for broader legalization say the final bill crosses a line by discarding rules meant to shield residents who use cannabis within the bounds of the law. Under the revised plan, anyone who possesses marijuana purchased outside Ohio’s regulated dispensaries or grown outside a permitted home-grow could face criminal penalties. For instance, someone carrying cannabis bought legally in Michigan could be charged once back in Ohio.

The bill also places new limits on where people can smoke or vape. Using cannabis in outdoor public spaces like bar patios would be prohibited, and landlords would be allowed to ban vaping at rental properties. Violating a landlord’s rule, even in a private backyard, could lead to a misdemeanor.

Lawmakers also rewrote plans for regulating intoxicating hemp products. Instead of establishing a new oversight structure, the final bill bars sales of products that exceed a low THC threshold or contain synthetic cannabinoids unless they are purchased through licensed dispensaries. This aligns with federal changes signed by President Donald Trump last month.

Federal rules give states a one-year window to implement the new hemp restrictions, but Ohio’s legislation appears to be moving faster. One exception covers cannabinoid beverages, which would fall under a temporary state program until the end of 2026.

Huffman argued on the Senate floor that the proposal preserves the basic framework of the voter-approved system while tightening rules to protect public safety and minors. Senator Bill DeMora countered that the bill defies the intent of the 2.2 million Ohioans who supported the 2023 measure. He said lawmakers have spent two years undoing what voters intended on issues ranging from home cultivation to how tax revenue flows to local communities.

Huffman has pushed back on that idea, saying voters changed the state code rather than the Constitution, which allows lawmakers to alter the statute. He maintains that most users will find the new rules workable.

Entities like Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) that have been involved in advocacy to reform marijuana laws in states like Florida are unlikely to be pleased by what is happening in Ohio where voters made their wishes known and passed a ballot measure but lawmakers are rolling back the scope of that voter-approved reform.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Judge Rejects Request to Halt Implementation of New Michigan Cannabis Taxes

A Michigan court has refused to pause the state’s newly approved 24% tax on wholesale marijuana, clearing the way for the levy to begin on January 1, 2026. The decision, issued by Court of Claims Judge Sima Patel, was closely watched by marijuana companies and policymakers who have debated for months whether the Legislature overstepped its authority when it added the tax to this year’s budget.

Patel sided with state officials who argued that the new charge does not alter the substance of the 2018 ballot measure that opened Michigan’s recreational cannabis market. State lawyers maintained that the voter-backed law remains intact and that the tax is simply a tool to raise money for infrastructure projects, particularly road improvements.

Patel noted that early drafts of the road funding measure already envisioned higher tax collections to support transportation, even though they did not spell out where those dollars would come from. According to the judge, the underlying purpose of the legislation stayed consistent.

Under the state’s Constitution, any revision to a voter-approved statute requires a three-quarters vote in both legislative chambers. The wholesale tax did not meet that bar, which became a central argument for the Michigan Cannabis Industry Association (MCIA).

The group contended that creating a new levy without overwhelming legislative support effectively changes the framework voters endorsed six years ago. Business owners have warned that layering a sizable wholesale tax on top of the existing retail excise tax could push some companies to the brink.

Industry representatives also cautioned that higher prices might push buyers back toward unlicensed sellers, undermining efforts to build a stable and regulated marketplace. The court said these predictions were too uncertain to justify blocking the policy.

MCIA spokesperson Rose Tantraphol said the organization intends to keep pressing its case, insisting that lawmakers ignored the intent of the electorate when they approved the budget provision.

A scheduling conference is planned for January 13 to determine how the case will proceed. The next formal step for the industry group is an appeal to the state’s Court of Appeals. Regardless of how that panel rules, both sides expect the issue to reach the state Supreme Court.

The wholesale levy, combined with the state’s existing 10% retail cannabis excise tax, will place Michigan among the states with the highest marijuana tax rates in the country.

Marijuana sales in Michigan are already showing signs of decline. Legal retailers reported $3.2 billion in revenue in 2024, making Michigan the second-largest marijuana market in the nation after California.

Companies like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) with operations in Michigan will be hoping that the legal process yields an outcome that doesn’t impose an exorbitant tax burden on licensed marijuana companies in the state.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Seed Ban in America Threatens to Drive Marijuana Genetics Underground

For the first time in six years, the U.S. is preparing to tighten rules on cannabis seeds after lawmakers inserted a last-minute clause into the recent federal spending package that reopened the government. Industry specialists warn that the change could wipe out the domestic seed market and reverse years of lenient oversight.

Marijuana seed producers have operated with relatively few restrictions since 2018. The shift followed the passage of the farm bill that year, which treated any plant material with less than 0.3% delta-9 THC as hemp. Since the seeds contain only trace amounts of the psychoactive compound, they were effectively removed from the Controlled Substances Act.

That interpretation became even clearer in 2022 when the DEA confirmed that cannabis seeds meeting the low-THC threshold are legally considered hemp, even if the plants that grow from them might later contain higher levels of THC.

The clarification allowed most states to permit seed sales and shipping without triggering narcotics laws. Companies have been able to import and sell seeds without special authorization, creating what many describe as the world’s most active seed marketplace.

The new spending bill, however, includes language that would prohibit a broad group of hemp-derived products. The language specifically targets viable seeds from the cannabis plants if the mature plants could exceed the 0.3% THC limit, including THCA, once dried. In practice, the rule would restrict seeds based on the potential potency of the future crop rather than the chemical makeup of the seeds themselves.

Many in the industry say this approach is unworkable. They note that growers cannot determine the future THC content of a plant until it has matured over several months. That leaves growers and companies with no reliable way to identify what would be considered legal under the proposal.

Consumers who grow their own plants could also feel the impact. Some states outlaw home cultivation entirely, while others allow limited growing, often tied to a medical card. New Holland Group CEO Jamie Pearson said patients who depend on specific strains for conditions such as epilepsy, chronic pain, or nausea risk losing access to varieties that currently help them.

The industry remains unsure how companies would be expected to prove that their seeds can only produce low-THC plants. Pearson believes only a small number of large companies would have the resources to meet any testing or certification requirements. She compared the range of seeds on the market today to the diversity found in wine grapes, which produce subtle differences across wide varieties.

If the ban proceeds, Pearson expects most of that diversity to disappear from the legal market. She warned that only major corporations with the right licenses would remain, while many unique genetics would move underground. In her view, consumers would lose the wide selection they are used to and be left with a far narrower set of options.

Companies like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) headquartered outside the U.S. may be wondering how long it will take America to adapt to the times and remove existing roadblocks to the widely accepted marijuana industry within the country.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Consumption Lounges Open New Opportunities for Marijuana Firms

Marijuana consumption lounges are reshaping the hospitality industry with experiences that blend social spaces and regulated cannabis use. What started as a niche concept with events like edible-friendly yoga or art sessions has developed into a broader push for dedicated spaces where adults can gather and consume legally.

According to Dale Sky Jones, chancellor of Oaksterdam University in Oakland, these venues represent the next significant development for the legal cannabis sector.

Jones argues that the appeal of lounges goes far beyond novelty. Operators who hope to succeed must handle compliance, consumer education, and guest safety with the same care that traditional hospitality businesses give to food and beverage service. Done well, she says, lounges can strengthen brand identity and open the door to new revenue opportunities.

According to Jones, the customer experience forms the backbone of any successful operation. Everything from interior design to staff training affects how visitors feel when they walk through the door. Air filtration, sound management for events, and thoughtful floor plans all contribute to what she described as a smooth and enjoyable visit.

Lounges also give businesses room to experiment. Operators are hosting comedy shows, concerts, and hybrid events that blend traditional nightlife with regulated consumption. Tribal governments may have an even stronger chance to innovate, since they can integrate cannabis into casinos, hotels, or other entertainment properties.

Even so, operators face significant challenges. State and local rules often treat cannabis separately from alcohol, leading to tougher regulations and higher insurance exposure for lounge owners.

Public education remains another hurdle. According to Jones, many policymakers still do not understand how the consumption lounges work or how they differ from unregulated consumption. She called on industry leaders to help educate local and state officials so that lounge models can expand responsibly.

Looking ahead, Jones believes cannabis brands most likely to succeed are those that focus on building recognizable lifestyle experiences. Cannabis products cannot move across state borders, she said, but a brand’s atmosphere and culture can. She also imagines a future where marijuana becomes part of everyday activities, including offerings tailored to older adults or pet-friendly environments.

Jones urged operators to approach the growing sector with a mix of creativity and accountability. By emphasizing safety, transparency, and thoughtful engagement with the community, she said, lounges can help set a new standard for what modern cannabis hospitality looks like.

As consumption lounges gain traction around the country, new business opportunities could open up for cannabis ecosystem players like Innovative Industrial Properties Inc. (NYSE: IIPR) that can tweak their offerings to address this emerging need.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Shows Marijuana Regulations Are Effective on Matters of Public Health

A new federally funded review of state regulations suggests that agencies overseeing legal cannabis are placing far greater emphasis on public health than the bodies responsible for alcohol oversight. The findings are based on an analysis of annual reports issued by regulatory agencies in all 24 states that permit recreational cannabis.

Researchers examined how each agency framed its mission, how often it reported working with health departments, and what types of public safety initiatives it highlighted. Roughly 68% of agencies that manage cannabis markets referenced public health priorities in their guiding statements, while only 35% of alcohol regulators did the same.

The findings challenge the familiar campaign message that cannabis should be regulated like alcohol. According to the study, in many cases, cannabis is subject to stronger oversight when it comes to health protections.

The study also found that the path a state took to legalize cannabis appears to influence how regulators approach their work. States where lawmakers approved legalization tended to produce agencies that reported more health-focused indicators, both for alcohol and cannabis, when compared with states that relied on ballot initiatives.

According to the study, legislative legalization has become more common in recent years, and these newer programs often document a broader set of public health concerns linked to cannabis use.

Across all states reviewed, marijuana agencies consistently cited public health goals more often than their alcohol counterparts. Alcohol regulators were more likely to highlight law enforcement activities, such as compliance checks or investigations, while cannabis agencies more frequently reported efforts tied to education, harm reduction, or collaboration with medical experts.

The authors stressed that the findings raise significant questions about the actual impact of regulatory decisions in the real world. They noted that additional work is needed to determine whether the public health strategies described in agency reports lead to measurable improvements for people who use cannabis or for communities affected by the industry’s growth.

The findings come as Congress is weighing how the federal government should prepare for a future in which marijuana is fully legal nationwide. A bipartisan group in the House has already introduced legislation that would require the attorney general to assemble a commission tasked with outlining a regulatory structure for marijuana modeled on the long-established approach used for alcohol.

At the same time, alcohol industry groups have pushed Congress to crack down on THC-infused hemp products and to create a regulatory framework for the sector.

As the regulatory landscape for marijuana evolves at the federal level, entities like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) will be closely watching and hoping that the regulatory headwinds they face ease over time.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com